|
1
|
Sondermann A, Andreghetto FM, Moulatlet
AC, da Silva Victor E, de Castro MG, Nunes FD, Brandão LG and
Severino P: MiR-9 and miR-21 as prognostic biomarkers for
recurrence in papillary thyroid cancer. Clin Exp Metastasis.
32:521–530. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xing M, Haugen BR and Schlumberger M:
Progress in molecular-based management of differentiated thyroid
cancer. Lancet. 381:1058–1069. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guan H, Liang W, Xie Z, Li H, Liu J, Liu
L, Xiu L and Li Y: Down-regulation of miR-144 promotes thyroid
cancer cell invasion by targeting ZEB1 and ZEB2. Endocrine.
48:566–574. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Geraldo MV, Fuziwara CS, Friguglieti CU,
Costa RB, Kulcsar MA, Yamashita AS and Kimura ET: MicroRNAs
miR-146-5p and let-7f as prognostic tools for aggressive papillary
thyroid carcinoma: A case report. Arq Bras Endocrinol Metabol.
56:552–557. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng H, Wang M, Jiang L, Chu H, Hu J,
Ning J, Li B, Wang D and Xu J: BRAF-activated long noncoding RNA
modulates papillary thyroid carcinoma cell proliferation through
regulating thyroid stimulating hormone receptor. Cancer Res Treat.
48:698–707. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schneider AB and Sarne DH: Long-term risks
for thyroid cancer and other neoplasms after exposure to radiation.
Nat Clin Pract Endocrinol Metab. 1:82–91. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deng X, Wu B, Xiao K, Kang J, Xie J, Zhang
X and Fan Y: MiR-146b-5p promotes metastasis and induces
epithelial-mesenchymal transition in thyroid cancer by targeting
ZNRF3. Cell Physiol Biochem. 35:71–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chou CK, Yang KD, Chou FF, Huang CC, Lan
YW, Lee YF, Kang HY and Liu RT: Prognostic implications of miR-146b
expression and its functional role in papillary thyroid carcinoma.
J Clin Endocrinol Metab. 98:E196–E205. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lang BH, Wong KP, Wan KY and Lo CY:
Significance of metastatic lymph node ratio on stimulated
thyroglobulin levels in papillary thyroid carcinoma after
prophylactic unilateral central neck dissection. Ann Surg Oncol.
19:1257–1263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qi J, Rice SJ, Salzberg AC, Runkle EA,
Liao J, Zander DS and Mu D: MiR-365 regulates lung cancer and
developmental gene thyroid transcription factor 1. Cell Cycle.
11:177–186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang HG, Luo X, Wu S and Jian B: MiR-99a
inhibits cell proliferation and tumorigenesis through targeting
mTOR in human anaplastic thyroid cancer. Asian Pac J Cancer Prev.
16:4937–4944. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Boufraqech M, Zhang L, Jain M, Patel D,
Ellis R, Xiong Y, He M, Nilubol N, Merino MJ and Kebebew E: miR-145
suppresses thyroid cancer growth and metastasis and targets AKT3.
Endocr Relat Cancer. 21:517–531. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bentwich I, Avniel A, Karov Y, Aharonov R,
Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, et al:
Identification of hundreds of conserved and nonconserved human
microRNAs. Nat Genet. 37:766–770. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nikiforova MN, Gandhi M, Kelly L and
Nikiforov YE: MicroRNA dysregulation in human thyroid cells
following exposure to ionizing radiation. Thyroid. 21:261–266.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: MicroRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stefani G and Slack FJ: Small non-coding
RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schmittgen TD: Regulation of microRNA
processing in development, differentiation and cancer. J Cell Mol
Med. 12:1811–1819. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rottiers V, Najafi-Shoushtari SH, Kristo
F, Gurumurthy S, Zhong L, Li Y, Cohen DE, Gerszten RE, Bardeesy N,
Mostoslavsky R and Näär AM: MicroRNAs in metabolism and metabolic
diseases. Cold Spring Harb Symp Quant Biol. 76:225–233. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bueno MJ and Malumbres M: MicroRNAs and
the cell cycle. Biochim Biophys Acta. 1812:592–601. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:pp. 2257–2261.
2006, View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ventura A and Jacks T: MicroRNAs and
cancer: Short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang T, Thakur A, Chen T, Yang L, Lei G,
Liang Y, Zhang S, Ren H and Chen M: MicroRNA-15a induces cell
apoptosis and inhibits metastasis by targeting BCL2L2 in non-small
cell lung cancer. Tumour Biol. 36:4357–4365. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ribeiro FR, Meireles AM, Rocha AS and
Teixeira MR: Conventional and molecular cytogenetics of human
non-medullary thyroid carcinoma: Characterization of eight cell
line models and review of the literature on clinical samples. BMC
Cancer. 8:3712008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dassow H and Aigner A: MicroRNAs (miRNAs)
in colorectal cancer: From aberrant expression towards therapy.
Curr Pharm Des. 19:1242–1252. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Meng Y, Zou Q, Liu T, Cai X, Huang Y and
Pan J: microRNA-335 inhibits proliferation, cell-cycle progression,
colony formation and invasion via targeting PAX6 in breast cancer
cells. Mol Med Rep. 11:379–385. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu Y, Zhao F, Wang Z, Song Y, Luo Y, Zhang
X, Jiang L, Sun Z, Miao Z and Xu H: MicroRNA-335 acts as a
metastasis suppressor in gastric cancer by targeting Bcl-w and
specificity protein 1. Oncogene. 31:1398–1407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiong SW, Lin TX, Xu KW, Dong W, Ling XH,
Jiang FN, Chen G, Zhong WD and Huang J: MicroRNA-335 acts as a
candidate tumor suppressor in prostate cancer. Pathol Oncol Res.
19:529–537. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun Z, Zhang Z, Liu Z, Qiu B, Liu K and
Dong G: MicroRNA-335 inhibits invasion and metastasis of colorectal
cancer by targeting ZEB2. Med Oncol. 31:9822014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shi L, Jiang D, Sun G, Wan Y, Zhang S,
Zeng Y, Pan T and Wang Z: miR-335 promotes cell proliferation by
directly targeting Rb1 in meningiomas. J Neurooncol. 110:155–162.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jiang J, Sun X, Wang W, Jin X, Bo X, Li Z,
Bian A, Jiu J, Wang X, Liu D, et al: Tumor microRNA-335 expression
is associated with poor prognosis in human glioma. Med Oncol.
29:3472–3477. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu Z, Ni L, Chen D, Zhang Q, Su Z, Wang Y,
Yu W, Wu X, Ye J, Yang S, et al: Identification of miR-7 as an
oncogene in renal cell carcinoma. J Mol Histol. 44:669–677. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bindels S, Mestdagt M, Vandewalle C,
Jacobs N, Volders L, Noël A, van Roy F, Berx G, Foidart JM and
Gilles C: Regulation of vimentin by SIP1 in human epithelial breast
tumor cells. Oncogene. 25:4975–4985. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kurashige J, Kamohara H, Watanabe M,
Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S, Baba Y and
Baba H: MicroRNA-200b regulates cell proliferation, invasion and
migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg
Oncol. 19 Suppl 3:S656–S664. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chu PY, Hu FW, Yu CC, Tsai LL, Yu CH, Wu
BC, Chen YW, Huang PI and Lo WL: Epithelial-mesenchymal transition
transcription factor ZEB1/ZEB2 co-expression predicts poor
prognosis and maintains tumor-initiating properties in head and
neck cancer. Oral Oncol. 49:34–41. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Qi S, Song Y, Peng Y, Wang H, Long H, Yu
X, Li Z, Fang L, Wu A, Luo W, et al: ZEB2 mediates multiple
pathways regulating cell proliferation, migration, invasion and
apoptosis in glioma. PLoS One. 7:e388422012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cai MY, Luo RZ, Chen JW, Pei XQ, Lu JB,
Hou JH and Yun JP: Overexpression of ZEB2 in peritumoral liver
tissue correlates with favorable survival after curative resection
of hepatocellular carcinoma. PLoS One. 7:e328382012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu Q, Guo R, Lin M, Zhou B and Wang Y:
MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration
and invasion by targeting E-cadherin repressor ZEB2. Gynecol Oncol.
122:149–154. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gemmill RM, Roche J, Potiron VA, Nasarre
P, Mitas M, Coldren CD, Helfrich BA, Garrett-Mayer E, Bunn PA and
Drabkin HA: ZEB1-responsive genes in non-small cell lung cancer.
Cancer Lett. 300:66–78. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Montemayor-Garcia C, Hardin H, Guo Z,
Larrain C, Buehler D, Asioli S, Chen H and Lloyd RV: The role of
epithelial mesenchymal transition markers in thyroid carcinoma
progression. Endocr Pathol. 24:206–212. 2013. View Article : Google Scholar : PubMed/NCBI
|
